Dermatomyositis Following BNT162b2 mRNA COVID-19 Vaccination-Reference-Cited by-同舟云学术

Dermatomyositis Following BNT162b2 mRNA COVID-19 Vaccination

Published:2022 Issue:5 Volume:37 Page:
ISSN:1011-8934
Container-title:Journal of Korean Medical Science
language:en
Short-container-title:J Korean Med Sci

Author:

Gouda Wesam¹²^ORCID,Albasri Anwar²³^ORCID,Alsaqabi Faisal²^ORCID,Al Sabah Humoud Y.⁴^ORCID,Alkandari Marwan⁵^ORCID,Abdelnaby Hassan⁶^ORCID

Affiliation:

1. Department of Rheumatology, Faculty of Medicine, Al Azhar University, Assiut, Egypt.

2. Department of Rheumatology, Al-Sabah Hospital, Kuwait, Kuwait.

3. Department of Rheumatology, Jaber Al Ahmad Hospital, Kuwait, Kuwait.

4. Asad Al Hamad Dermatology Center, Kuwait, Kuwait.

5. Department of Radiodiagnosis, Al-Sabah Hospital, Kuwait, Kuwait.

6. Department of Endemic and Infectious Diseases, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.

Publisher

Korean Academy of Medical Sciences

Subject

General Medicine

Link

https://jkms.org/pdf/10.3346/jkms.2022.37.e32

Reference20 articles.

1. University of Oxford. Statistics and research. Coronavirus (COVID-19) vaccinations. Updated 2021. Accessed March 5 2021. https://ourworldindata.org/covid-vaccinations

2. Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19

3. Polymyositis and Dermatomyositis

4. Polymyositis and Dermatomyositis

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-MDA5 autoantibodies predict clinical dynamics of dermatomyositis following SARS-CoV-2 mRNA vaccination: a retrospective statistical analysis of case reports;Rheumatology International;2024-08-27

2. MDA5-autoimmunity and interstitial pneumonitis contemporaneous with the COVID-19 pandemic (MIP-C);eBioMedicine;2024-06

3. Development of Dermatomyositis after Pfizer BioNTeh COVID-19 Vaccine: A Case Report;Current Drug Safety;2024-05

4. Interferon-γ Release Assay in the Assessment of Cellular Immunity—A Single-Centre Experience with mRNA SARS-CoV-2 Vaccine in Patients with Juvenile Idiopathic Arthritis;Journal of Clinical Medicine;2024-04-25

5. Clinical and immunological features of COVID‐19 in patients with anti‐MDA5 dermatomyositis during the omicron wave in Chongqing, China;Journal of Medical Virology;2024-03